Phibro Animal Health Corp (PAHC) Insider Sells $356,200.00 in Stock

Phibro Animal Health Corp (NASDAQ:PAHC) insider Dean J. Warras sold 10,000 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $35.62, for a total transaction of $356,200.00. Following the completion of the transaction, the insider now directly owns 10,000 shares in the company, valued at approximately $356,200. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Phibro Animal Health Corp (NASDAQ PAHC) traded down $0.40 on Tuesday, hitting $35.05. The stock had a trading volume of 109,103 shares, compared to its average volume of 80,197. The company has a market capitalization of $1,428.79, a PE ratio of 22.91, a PEG ratio of 2.52 and a beta of 1.18. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.75 and a current ratio of 3.12. Phibro Animal Health Corp has a 52 week low of $26.70 and a 52 week high of $40.25.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, February 5th. The company reported $0.44 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.06. The company had revenue of $205.90 million for the quarter, compared to analysts’ expectations of $194.90 million. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 earnings per share. equities analysts forecast that Phibro Animal Health Corp will post 1.69 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th will be issued a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, March 6th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.14%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 26.14%.

Several institutional investors and hedge funds have recently added to or reduced their stakes in PAHC. Renaissance Technologies LLC increased its stake in shares of Phibro Animal Health by 16.4% during the fourth quarter. Renaissance Technologies LLC now owns 463,496 shares of the company’s stock valued at $15,527,000 after acquiring an additional 65,396 shares during the period. Investors Research Corp acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at approximately $433,000. Spark Investment Management LLC increased its stake in shares of Phibro Animal Health by 129.5% during the fourth quarter. Spark Investment Management LLC now owns 47,500 shares of the company’s stock valued at $1,591,000 after acquiring an additional 26,800 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in shares of Phibro Animal Health by 37.4% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock valued at $8,159,000 after acquiring an additional 66,300 shares during the period. Finally, Citadel Advisors LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at approximately $293,000. 48.42% of the stock is currently owned by institutional investors.

A number of brokerages have issued reports on PAHC. Credit Suisse Group raised their target price on shares of Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a report on Tuesday, February 6th. Morgan Stanley lifted their price target on Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a report on Wednesday, February 7th. Zacks Investment Research raised Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price target on the stock in a report on Thursday, February 8th. BidaskClub raised Phibro Animal Health from a “strong sell” rating to a “sell” rating in a report on Saturday, January 6th. Finally, ValuEngine cut Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $38.20.

TRADEMARK VIOLATION WARNING: “Phibro Animal Health Corp (PAHC) Insider Sells $356,200.00 in Stock” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/13/phibro-animal-health-corp-pahc-insider-sells-356200-00-in-stock.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply